This resource has been updated.
There is no cost for this toolkit. To access content items indexed below on this page, sign in or log in using your NASN website user account or create one. Click on each item for a description and link to download.
Opioid drug abuse is a concern that affects the entire community. The decision to implement a stock naloxone program in schools should be a community decision. The school nurse is a leader in student health and has the education and expertise to assist the community and school leadership in assessing the need for a stock naloxone program.
This toolkit offers numerous resources to assist school nurses and other school leaders to evaluate and respond to the opioid epidemic appropriately.
Naloxone Education for School Nurses Toolkit was developed by a workgroup that included school health services leaders in the National Association of School Nurses (NASN) and the National Association of State School Nurse Consultants (NASSNC).
The members of the workgroup are as follows:
- Teresa DuChateau, DNP, RN, CPNP, School Health Services Consultant, School Health Associates, LLC, Project Leader
- Beth Anne Bahn, MSN, RN, CRNP, CSN, Director Division of School Health, Pennsylvania Department of Health, NASSNC
- Nancy Dube, RN MPH, School Nurse Consultant, Maine Department of Education, NASSNC
- Rebecca King, MSN, RN, NCSN, School Nurse/ Clinical Nursing Instructor St. George's Technical High School, Delaware NASN Director, Past NASN Executive Committee, Board of Directors "atTAcK addiction”
- Lori Mido, MSN, RN, NJ-CSN, School Nurse, Oak Ridge Heights School #21, New Jersey, NASN
- Kathleen Patrick, MA, BSN, RN, NCSN, FNASN, Assistant Director, Health and Wellness/State School Nurse Consultant, Colorado Department of Education, NASSNC
- Danielle Harris, BA, Program Manager/Graphic Designer
- Sharon Conley, BA, Director of Web-based Technology and Digital Communications
- Margaret Cellucci, BA, Director of Communications
Naloxone Education for School Nurses Toolkit was created from an unrestricted grant from ADAPT Pharma.